Real-world effectiveness of dupilumab in patients with severe asthma in Europe: Findings from the EU-ADVANTAGE study
- DOI
- 10.1016/j.rmed.2026.109211
- Published
- 2026-11
- Container
- Respiratory Medicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.rmed.2026.109211,
title = {Real-world effectiveness of dupilumab in patients with severe asthma in Europe: Findings from the EU-ADVANTAGE study},
author = {Arnaud Bourdin and Giorgio Walter Canonica and Johann Christian Virchow and Juby Jacob-Nara and Kinga Borsos and Richard H. Stanford and Zhixiao Wang and Xavier Soler and Lynn Huynh and Andra Boca and Mei Sheng Duh and Wei-Han Cheng and Aakash Gandhi},
year = {2026},
journal = {Respiratory Medicine},
doi = {10.1016/j.rmed.2026.109211},
url = {https://doi.org/10.1016/j.rmed.2026.109211}
}RIS
TY - JOUR TI - Real-world effectiveness of dupilumab in patients with severe asthma in Europe: Findings from the EU-ADVANTAGE study AU - Arnaud Bourdin AU - Giorgio Walter Canonica AU - Johann Christian Virchow AU - Juby Jacob-Nara AU - Kinga Borsos AU - Richard H. Stanford AU - Zhixiao Wang AU - Xavier Soler AU - Lynn Huynh AU - Andra Boca AU - Mei Sheng Duh AU - Wei-Han Cheng AU - Aakash Gandhi PY - 2026 JO - Respiratory Medicine DO - 10.1016/j.rmed.2026.109211 UR - https://doi.org/10.1016/j.rmed.2026.109211 ER -
APA
Bourdin, A., Canonica, G. W., Virchow, J. C., Jacob-Nara, J., Borsos, K., Stanford, R. H., Wang, Z., Soler, X., Huynh, L., Boca, A., Duh, M. S., Cheng, W., & Gandhi, A. (2026). Real-world effectiveness of dupilumab in patients with severe asthma in Europe: Findings from the EU-ADVANTAGE study. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2026.109211
Source records
- crossref · retrieved 2026-11-10T15:00:32.634Z